Kazianis S, Morizot D C, Coletta L D, Johnston D A, Woolcock B, Vielkind J R, Nairn R S
Department of Carcinogenesis, Science Park-Research Division, MD Anderson Cancer Center, University of Texas, Smithville, Texas, TX 78957-0389, USA.
Oncogene. 1999 Sep 9;18(36):5088-99. doi: 10.1038/sj.onc.1202884.
We have cloned, sequenced, and characterized the RNA expression properties of a fish CDKN2 gene from Xiphophorus helleri and X. maculatus. This gene, termed CDKN2X, shows a high degree of amino acid sequence similarity to members of the mammalian CDKN2 gene family, which includes the tumor suppressor loci CDKN2A (P16) and CDKN2B (P15). Comparative sequence analysis suggests that fish CDKN2X is similarly related to all four mammalian gene family members, and may represent a descendant of an ancestral prototypic CDKN2 gene. CDKN2X was mapped to a region on autosomal Xiphophorus linkage group V (LG V) known to contain the DIFF gene that acts as a tumor suppressor of melanoma formation in X. helleri/X. maculatus backcross hybrids. Thus, CDKN2X may be a candidate for the tumor suppressor DIFF gene. Here we have sequenced CDKN2X in both Xiphophorus species and have characterized its expression in normal and melanotic tissues within control and backcross hybrid fish. A simultaneous expressional analysis of the Xmrk-2 tyrosine kinase receptor gene, which is strongly implicated in melanomagenesis in this system, was also performed. RT - PCR analyses revealed that both genes were highly expressed in melanomas. For CDKN2X, this result contrasts numerous findings in human tumors including human melanoma in which either CDKN2A (P16) deactivation or LOH was observed.
我们已经克隆、测序并鉴定了来自剑尾鱼(Xiphophorus helleri)和斑剑尾鱼(X. maculatus)的一个鱼类CDKN2基因的RNA表达特性。这个基因,称为CDKN2X,与哺乳动物CDKN2基因家族的成员具有高度的氨基酸序列相似性,该家族包括肿瘤抑制基因座CDKN2A(P16)和CDKN2B(P15)。比较序列分析表明,鱼类CDKN2X与所有四个哺乳动物基因家族成员的关系相似,可能代表了一个祖先原型CDKN2基因的后代。CDKN2X被定位到剑尾鱼常染色体连锁群V(LG V)上的一个区域,已知该区域包含DIFF基因,该基因在剑尾鱼/斑剑尾鱼回交杂种中作为黑色素瘤形成的肿瘤抑制因子。因此,CDKN2X可能是肿瘤抑制基因DIFF的候选基因。在这里,我们对两种剑尾鱼的CDKN2X进行了测序,并鉴定了其在对照鱼和回交杂种鱼的正常组织和黑色素瘤组织中的表达情况。同时,还对Xmrk-2酪氨酸激酶受体基因进行了表达分析,该基因在这个系统中与黑色素瘤的发生密切相关。逆转录-聚合酶链反应(RT-PCR)分析显示,这两个基因在黑色素瘤中均高表达。对于CDKN2X,这一结果与在人类肿瘤(包括人类黑色素瘤)中的众多发现形成对比,在人类肿瘤中观察到了CDKN2A(P16)失活或杂合性缺失。